Molibresib

Molibresib (GSK525762) 是一种 BET 溴结构域抑制剂,IC50为32.5在42.5 nM 之间。

CAS号

1260907-17-2

分子式

C22H22ClN5O2

主要靶点

Epigenetic Reader Domain

仅限科研使用

Cat No : CM03971

Print datasheet

Synonyms

I-BET 762|GSK 525762A|GSK525762|(4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-a][1,4]苯并二氮杂卓-4-乙酰胺



产品信息

GSK 525762A (I-BET 762) is an inhibitor of BET proteins (IC50: about 35 nM).

CAS号 1260907-17-2
分子式 C22H22ClN5O2
主要靶点 Epigenetic Reader Domain
主要通路 表观遗传
分子量 423.9
纯度 98.82%, 此纯度可做参考,具体纯度与批次有关系,可咨询客服
储存条件 Powder: -20°C for 3 years | In solvent: -80°C for 1 year
别名 I-BET 762|GSK 525762A|GSK525762|(4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-a][1,4]苯并二氮杂卓-4-乙酰胺

靶点活性

BET proteins:35 nM

体内活性

在分化的第2天,I-BET-762处理可改变CD4+T细胞的细胞因子产生,使一些抗炎基因产物的表达上调,并使一些促炎细胞因子的表达下调。I-BET-762抑制溴区和额外的末端结构域的蛋白和BRD2/3/4结合到BET的串联溴区(Kd:50.5-61.3 nM), 在FRET分析中,置换BET串联溴区一种四乙酰化的H4肽(IC50:32.5-42.5 nM)。

体外活性

连续两天每日注射两次I-BET-762,可使小鼠免于脓毒症造成的死亡.I-BET-762可防止细菌诱导的脓毒病和脂多糖诱导的内毒素休克.脂多糖注射后1.5 h,I-BET-762可治愈小鼠.在实验性自身免疫性脑脊髓炎小鼠模型中,I-BET-762早期处理可抑制Th1分化的2D2 T细胞诱发神经性炎症的能力.

溶解度

H2O:<1 mg/mL,DMSO:78 mg/mL (184 mM),Ethanol:39 mg/mL (92 mM)

细胞实验

CD4+ T cells are isolated from lymph nodes and spleens of 10- to 12-wk old mice and activated with plate bound anti-CD3 and anti-CD28 antibodies in the presence of indicated cytokines. I-BET-762 compounds is included during the 60–72 h of initial activation. Over the course of 5 d of T-cell culture and expansion, the compounds is diluted 12-fold relative to the starting concentrations.(Only for Reference)

参考文献

1.Nicodeme E, et al. Nature, 2010, 468(7327), 1119-1123.
2.Bandukwala HS, et al. PNAS, 2012, 109(36), 14532-14537.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
=
×
×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
×
=
×
C1   V1   C2   V2